Abstract: Present invention refers to tooth re-mineralization materials incorporating calcium phosphates and calcium-free silicon compounds. Materials are efficacious in re-mineralization of teeth and occlusion of exposed dentinal tubules either when used alone or in dentifrice preparations for oral healthcare. Preferred calcium phosphates include anhydrous dicalcium phosphate, dicalcium phosphate dihydrate, hydroxyapatite and amorphous calcium phosphate that can incorporate partial substitutions of calcium by divalent metallic ions such as Mg++, Zn++, Ba++, Fe++, Sn++ and Sr++. Preferred calcium-free silicon compounds include silicon oxide, silica gel, methasilicic acid, orthosilicic acid, silicic acid, and combinations thereof.

Abstract: The present invention incorporates new materials for bone regeneration, methods for their manufacture, and application in traumatology surgery, maxillofacial surgery, dental surgery, orthognatic surgery, endodontics, ophthalmology, neurosurgery and/or osteoporotic processes, and other indications where bone regeneration is required. In particular, the present invention incorporates synthetic materials with a 20% to a 95%, preferably between 40% and 90% in mass of monetite [Ca1-XMXHPO4, where 0?x?0.05, and where M can be a divalent metallic ion], and which in their final composition incorporate between 5% and 80%, preferably between 0% and 60%, in mass of bioactive calcium compounds chosen from calcium phosphates and between 5% and 80% in total mass of bioactive silicon compounds chosen from calcium silicates and/or bioactive silica glasses and gels.

Abstract: The present invention incorporates new materials for bone regeneration, methods for their manufacture, and application in traumatology surgery, maxillo facial surgery, dental surgery, orthognatic surgery, endodontics, ophthalmology, neurosurgery and/or osteoporotic processes, and other indications where bone regeneration is required. In particular, the present invention incorporates synthetic materials with a 20% to a 95%, preferably between 40% and 90% in mass of monetite [Ca1-XMXHPO4, where 0?x?0.05, and where M can be a divalent metallic ion], and which in their final composition incorporate between 5% and 80%, preferably between 0% and 60%, in mass of bioactive calcium compounds chosen from calcium phosphates and between 5% and 80% in total mass of bioactive silicon compounds chosen from calcium silicates and/or bioactive silica glasses and gels.